.

Rigel Pharmaceuticals reported $-13492000 in Pre-Tax Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agenus AGEN:US $ -49.24M 1.37M
Anika Therapeutics ANIK:US $ -3.28M 0.42M
Applied Genetic Technologies AGTC:US $ -18.31M 4.07M
Arrowhead Research ARWR:US $ -72.05M 116.41M
AstraZeneca AZN:LN 258259.83M 36783.7M
Biomarin Pharmaceutical BMRN:US $ 34.85M 8.66M
Celldex Therapeutics CLDX:US $ -36M 12.95M
Chemocentryx CCXI:US $ -31.65M 6.96M
Daiichi Sankyo 4568:JP Y 29415M 81785M
Halozyme Therapeutics HALO:US $ 30.01M 51.62M
Immunogen IMGN:US $ -62.02M 37.88M
Intrexon XON:US $ -26.15M 6.84M
IONIS PHARMACEUT IONS:US $ -103M 39M
Karyopharm Therapeutics KPTI:US $ -48941000 7.67M
Macrogenics MGNX:US $ -41.3M 25.14M
Neurocrine Biosciences NBIX:US $ -23.3M 44.7M
Rigel Pharmaceuticals RIGL:US $ -13.49M 13.95M
Sangamo Biosciences SGMO:US $ -43.09M 0.83M
Ultragenyx Pharmaceutical RARE:US $ -157.86M 6.1M
Veracyte VCYT:US $ -9.65M 4.82M